Home > Drug Search >
  • Targets: Deoxyribonucleic acid helicase (DNA helicase)
  •   > 
Drug Filter
Status:
Approved (4) Withdrawn (1) Phase Ⅲ (3) Phase Ⅱ (16) Phase Ⅰ (9) IND Filing (1)
Clinical Stage:
Pending (6) Active (13) Discontinued (10)
Company:
GlaxoSmithKline (4) Lilly (1) Lundbeck (1) Novartis (3) Orion (1) Otsuka (1) Pfizer (4) Roche (3) SOBI (1) Unknown (2) Funxional Therapeutics (FXT) (1) Mereo BioPharma (1) Biotie (2) QuatRx Pharmaceuticals (1) Axovant (1) HEC Pharm (1) Oregon State University (1) Meditrina Pharmaceuticals (2) Suven Life Sciences (1) Avineuro (3) AllaChem (1) ChemDiv (1) Reviva Pharmaceuticals (1) Astellas (1) AstraZeneca (3) Bayer (1) Boehringer Ingelheim (1) Bristol-Myers Squibb (1)
Indication:
Advanced breast cancer (1) Alzheimer's disease (AD) (10) Anxiety (1) Asthma (1) Breast cancer (5) Chronic obstructive pulmonary disease (COPD) (4) Cognitive disorders (1) Cushing's disease (1) Endometriosis (2) Glioblastoma multiforme (1) Myelodysplastic syndrome (MDS) (1) Obesity (1) Parkinson's disease (PD) (1) Prostate cancer (2) Rheumatoid arthritis (RA) (1) Schizophrenia (4) Solid tumours (1) Colorectal cancer (1) Uterine leiomyoma (1) Advanced breast cancer in postmenopausal women (1) Estrogen-receptor positive early breast cancer (1) Hypogonadism (1) Menstruation disorders (1) Inflammation (1) Urination disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top